Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W Robinson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2021
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapiesShamin Li, Yannick Simoni, Summer Zhuang, et al.
BMC Cancer|December 19, 2014
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40Andrea Khong, Amanda L Cleaver, Muhammad Fahmi Alatas, et al.
BMC Research Notes|December 7, 2018
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptorsJonathan Chee, Mark W Watson, Abha Chopra, et al.
Translational Lung Cancer Research|October 21, 2024
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesotheliomaLinda Ye, Heeju Ryu, David Granadier, et al.
Oncoimmunology|October 6, 2018
Combination immune checkpoint blockade as an effective therapy for mesotheliomaVanessa S Fear, Caitlin Tilsed, Jonathan Chee, et al.
Oncoimmunology|July 4, 2015
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogenJenette Creaney, Shaokang Ma, Sophie A Sneddon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Oxford Open Immunology|January 23, 2026
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patientsNicola Principe, Kofi L P Stevens, Amber-Lee Phung, et al.
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2021
Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapiesShamin Li, Yannick Simoni, Summer Zhuang, et al.
BMC Cancer|December 19, 2014
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40Andrea Khong, Amanda L Cleaver, Muhammad Fahmi Alatas, et al.
BMC Research Notes|December 7, 2018
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptorsJonathan Chee, Mark W Watson, Abha Chopra, et al.
Translational Lung Cancer Research|October 21, 2024
Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesotheliomaLinda Ye, Heeju Ryu, David Granadier, et al.
Oncoimmunology|October 6, 2018
Combination immune checkpoint blockade as an effective therapy for mesotheliomaVanessa S Fear, Caitlin Tilsed, Jonathan Chee, et al.
Oncoimmunology|July 4, 2015
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogenJenette Creaney, Shaokang Ma, Sophie A Sneddon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
Oxford Open Immunology|January 23, 2026
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patientsNicola Principe, Kofi L P Stevens, Amber-Lee Phung, et al.
Plos One|January 11, 2018
Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencingAnn-Marie Patch, Katia Nones, Stephen H Kazakoff, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Pageof 4